CODX logo

Co-Diagnostics (CODX) EBITDA

Annual EBITDA

-$41.48 M
-$31.17 M-302.34%

December 31, 2023

Summary

Performance

1-Year Change

-302.34%

3-Year Change

-199.15%

5-Year Change

-581.5%

15-Year Change

-528.12%

CODX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.44%
CODX annual EBITDA is higher than 36.44% of companies in Healthcare sector

High & Low

All-time High

$46.40 M
CODX annual EBITDA is currently -189.39% below its historical high of $46.40 million

3-Year Low

-$41.48 M
CODX annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CODX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
CODX next annual earnings announcement is scheduled for Mar 14, 2025

OtherCODXprofitabilitymetrics:

Annual Revenue

$6.81 M
CODX annual revenue is $6.81 million

Annual Net Income

-$35.33 M
CODX annual net profit is -$35.33 million

Annual EBIT

-$42.71 M
CODX annual earnings before interest & taxes is -$42.71 million

Annual EPS

-$1.20
CODX annual earnings per share is -$1.20

Quarterly EBITDA

-$9.88 M
-$2.54 M-34.63%

September 30, 2024

Summary

Performance

3-Month Change

-34.63%

1-Year Change

+14.15%

3-Year Change

+14.15%

5-Year Change

+14.15%

CODX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.85%
CODX quarterly EBITDA is higher than 35.85% of companies in Healthcare sector

High & Low

All-time High

$16.09 M
CODX quarterly EBITDA is currently -161.44% below its historical high of $16.09 million

3-Year Low

-$11.69 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CODX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CODX next earnings announcement is scheduled for Mar 14, 2025

OtherCODXprofitabilitymetrics:

Quarterly Revenue

$641.10 K
CODX quarterly revenue is $641.10 thousand

Quarterly Net Income

-$9.70 M
CODX quarterly net profit is -$9.70 million

Quarterly EBIT

-$10.23 M
CODX quarterly earnings before interest & taxes is -$10.23 million

Quarterly EPS

-$0.32
CODX quarterly earnings per share is -$0.32

TTM EBITDA

-$38.67 M
-$1.24 M-3.32%

September 30, 2024

Summary

Performance

3-Month Change

-3.32%

1-Year Change

+6.77%

3-Year Change

+6.77%

5-Year Change

+6.77%

CODX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.61%
CODX TTM EBITDA is higher than 36.61% of companies in Healthcare sector

High & Low

All-time High

$53.30 M
CODX TTM EBITDA is currently -172.55% below its historical high of $53.30 million

3-Year Low

-$41.77 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CODX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CODX next earnings announcement is scheduled for Mar 14, 2025

OtherCODXprofitabilitymetrics:

TTM Revenue

$7.11 M
CODX TTM revenue is $7.11 million

TTM Net Income

-$41.28 M
CODX TTM net profit is -$41.28 million

TTM EBIT

-$40.00 M
CODX TTM earnings before interest & taxes is -$40.00 million

TTM EPS

-$1.38
CODX TTM earnings per share is -$1.38

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$41.48 M
CODX annual EBITDA is -$41.48 million

Annual Net Income

-$35.33 M
CODX annual net profit is -$35.33 million

Annual Interest Expense

-
CODX annual interest expense value is unknown

Annual Income Tax

-$2.78 M
CODX annual income tax is -$2.78 million

Annual D&A

$1.23 M
CODX annual depreciation & amortization is $1.23 million

CODX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-302.3%+14.2%+6.8%
3 y3 years-199.2%+14.2%+6.8%
5 y5 years-581.5%+14.2%+6.8%

CODX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-189.4%at low-194.9%+15.4%-183.3%+7.4%
5 y5-year-189.4%at low-161.4%+15.4%-172.6%+7.4%
alltimeall time-189.4%at low-161.4%+15.4%-172.6%+7.4%

Co-Diagnostics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.88 M(+34.6%)
-$38.67 M(+3.3%)
Jun 2024
-
-$7.34 M(-26.1%)
-$37.42 M(-10.4%)
Mar 2024
-
-$9.93 M(-13.8%)
-$41.77 M(+0.7%)
Dec 2023
-$41.48 M(+302.3%)
-$11.51 M(+33.3%)
-$41.48 M(+2.7%)
Sep 2023
-
-$8.64 M(-26.1%)
-$40.40 M(+6.4%)
Jun 2023
-
-$11.69 M(+21.3%)
-$37.98 M(+26.5%)
Mar 2023
-
-$9.63 M(-7.7%)
-$30.01 M(+191.2%)
Dec 2022
-$10.31 M(-122.2%)
-$10.43 M(+67.7%)
-$10.31 M(-197.8%)
Sep 2022
-
-$6.22 M(+67.2%)
$10.54 M(-65.4%)
Jun 2022
-
-$3.72 M(-137.0%)
$30.48 M(-33.8%)
Mar 2022
-
$10.07 M(-3.3%)
$46.07 M(-0.7%)
Dec 2021
$46.40 M(+10.9%)
$10.41 M(-24.1%)
$46.40 M(-10.9%)
Sep 2021
-
$13.72 M(+15.7%)
$52.08 M(+3.3%)
Jun 2021
-
$11.86 M(+14.0%)
$50.42 M(-5.4%)
Mar 2021
-
$10.40 M(-35.3%)
$53.30 M(+27.4%)
Dec 2020
$41.83 M
$16.09 M(+33.2%)
$41.83 M(+74.1%)
Sep 2020
-
$12.07 M(-18.1%)
$24.03 M(+135.0%)
Jun 2020
-
$14.73 M(-1488.4%)
$10.23 M(-275.2%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$1.06 M(-38.2%)
-$5.84 M(-3.1%)
Dec 2019
-$6.02 M(-1.0%)
-$1.72 M(-0.9%)
-$6.02 M(-2.2%)
Sep 2019
-
-$1.73 M(+30.3%)
-$6.16 M(+2.5%)
Jun 2019
-
-$1.33 M(+6.4%)
-$6.01 M(-0.5%)
Mar 2019
-
-$1.25 M(-32.5%)
-$6.04 M(-0.8%)
Dec 2018
-$6.09 M(-7.8%)
-$1.85 M(+17.0%)
-$6.09 M(+6.2%)
Sep 2018
-
-$1.58 M(+16.2%)
-$5.73 M(-28.5%)
Jun 2018
-
-$1.36 M(+4.8%)
-$8.02 M(+9.1%)
Mar 2018
-
-$1.30 M(-13.0%)
-$7.35 M(+11.3%)
Dec 2017
-$6.60 M(+300.1%)
-$1.49 M(-61.4%)
-$6.60 M(+19.0%)
Sep 2017
-
-$3.87 M(+460.4%)
-$5.55 M(+168.5%)
Jun 2017
-
-$689.90 K(+24.4%)
-$2.07 M(+17.6%)
Mar 2017
-
-$554.60 K(+27.0%)
-$1.76 M(-43.8%)
Dec 2016
-$1.65 M(-14.3%)
-$436.60 K(+13.4%)
-$3.13 M(+16.2%)
Sep 2016
-
-$385.10 K(+1.0%)
-$2.69 M(+16.7%)
Jun 2016
-
-$381.40 K(-80.2%)
-$2.31 M(+19.8%)
Mar 2016
-
-$1.92 M
-$1.92 M
Dec 2015
-$1.92 M
-
-

FAQ

  • What is Co-Diagnostics annual EBITDA?
  • What is the all time high annual EBITDA for Co-Diagnostics?
  • What is Co-Diagnostics annual EBITDA year-on-year change?
  • What is Co-Diagnostics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Co-Diagnostics?
  • What is Co-Diagnostics quarterly EBITDA year-on-year change?
  • What is Co-Diagnostics TTM EBITDA?
  • What is the all time high TTM EBITDA for Co-Diagnostics?
  • What is Co-Diagnostics TTM EBITDA year-on-year change?

What is Co-Diagnostics annual EBITDA?

The current annual EBITDA of CODX is -$41.48 M

What is the all time high annual EBITDA for Co-Diagnostics?

Co-Diagnostics all-time high annual EBITDA is $46.40 M

What is Co-Diagnostics annual EBITDA year-on-year change?

Over the past year, CODX annual EBITDA has changed by -$31.17 M (-302.34%)

What is Co-Diagnostics quarterly EBITDA?

The current quarterly EBITDA of CODX is -$9.88 M

What is the all time high quarterly EBITDA for Co-Diagnostics?

Co-Diagnostics all-time high quarterly EBITDA is $16.09 M

What is Co-Diagnostics quarterly EBITDA year-on-year change?

Over the past year, CODX quarterly EBITDA has changed by +$1.63 M (+14.15%)

What is Co-Diagnostics TTM EBITDA?

The current TTM EBITDA of CODX is -$38.67 M

What is the all time high TTM EBITDA for Co-Diagnostics?

Co-Diagnostics all-time high TTM EBITDA is $53.30 M

What is Co-Diagnostics TTM EBITDA year-on-year change?

Over the past year, CODX TTM EBITDA has changed by +$2.81 M (+6.77%)